MCID: CHR603
MIFTS: 21

Chronic Enteropathy Associated with Slco2a1 Gene

Categories: Gastrointestinal diseases, Rare diseases

Aliases & Classifications for Chronic Enteropathy Associated with Slco2a1 Gene

MalaCards integrated aliases for Chronic Enteropathy Associated with Slco2a1 Gene:

Name: Chronic Enteropathy Associated with Slco2a1 Gene 55
Ceas 55

Classifications:



External Ids:

Orphanet 55 ORPHA468641

Summaries for Chronic Enteropathy Associated with Slco2a1 Gene

MalaCards based summary : Chronic Enteropathy Associated with Slco2a1 Gene, also known as ceas, is related to bile duct carcinoma and colorectal cancer. An important gene associated with Chronic Enteropathy Associated with Slco2a1 Gene is SLCO2A1 (Solute Carrier Organic Anion Transporter Family Member 2A1).

Related Diseases for Chronic Enteropathy Associated with Slco2a1 Gene

Diseases related to Chronic Enteropathy Associated with Slco2a1 Gene via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 116)
# Related Disease Score Top Affiliating Genes
1 bile duct carcinoma 11.0
2 colorectal cancer 10.5
3 lung cancer 10.4
4 gastric cancer 10.3
5 adenocarcinoma 10.3
6 small cell cancer of the lung 10.3
7 breast cancer 10.2
8 pancreatitis 10.2
9 vaccinia 10.1
10 pancreatic cancer 10.1
11 peritonitis 10.1
12 squamous cell carcinoma 10.0
13 thyroiditis 10.0
14 aging 10.0
15 prostatitis 10.0
16 hepatitis 9.9
17 neuronitis 9.9
18 colorectal adenocarcinoma 9.9
19 transitional cell carcinoma 9.9
20 alpha-fetoprotein deficiency 9.8
21 endotheliitis 9.8
22 cystadenocarcinoma 9.8
23 endocervicitis 9.8
24 ovarian cancer 9.8
25 leukemia 9.8
26 polykaryocytosis inducer 9.8
27 prostate cancer 9.8
28 blood group, i system 9.8
29 surfactant metabolism dysfunction, pulmonary, 1 9.8
30 ring chromosome y syndrome 9.8
31 surfactant metabolism dysfunction, pulmonary, 4 9.8
32 hepatocellular carcinoma 9.8
33 adenoma 9.8
34 cataract 5, multiple types 9.8
35 melanoma 9.8
36 mycobacterium tuberculosis 1 9.8
37 thyroid carcinoma, familial medullary 9.8
38 esophagitis 9.8
39 surfactant metabolism dysfunction, pulmonary, 3 9.8
40 pancreas adenocarcinoma 9.8
41 carotid stenosis 9.8
42 bladder cancer 9.8
43 endometrial adenocarcinoma 9.8
44 cholangiocarcinoma 9.8
45 takenouchi-kosaki syndrome 9.7
46 endocervical adenocarcinoma 9.7
47 thyroid cancer 9.7
48 mucinous adenocarcinoma 9.7
49 basal cell carcinoma 1 9.7
50 anhidrosis 9.7

Graphical network of the top 20 diseases related to Chronic Enteropathy Associated with Slco2a1 Gene:



Diseases related to Chronic Enteropathy Associated with Slco2a1 Gene

Symptoms & Phenotypes for Chronic Enteropathy Associated with Slco2a1 Gene

Drugs & Therapeutics for Chronic Enteropathy Associated with Slco2a1 Gene

Search Clinical Trials , NIH Clinical Center for Chronic Enteropathy Associated with Slco2a1 Gene

Genetic Tests for Chronic Enteropathy Associated with Slco2a1 Gene

Anatomical Context for Chronic Enteropathy Associated with Slco2a1 Gene

Publications for Chronic Enteropathy Associated with Slco2a1 Gene

Articles related to Chronic Enteropathy Associated with Slco2a1 Gene:

(show top 50) (show all 732)
# Title Authors Year
1
Clinical Performance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer Using LOCIa8c-based Assays. ( 28011514 )
2017
2
Interdigitating dendritic cell sarcoma successfully treated with ABVD therapy in which serum CEA levels correlated with disease activity. ( 28484155 )
2017
3
Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules. ( 28545454 )
2017
4
Elevated Preoperative Serum CEA Level Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma Through the Epithelial-Mesenchymal Transition. ( 28314278 )
2017
5
Balanced secretion of anti-CEA A9 anti-CD3 diabody chains using the 2A self-cleaving peptide maximizes diabody assembly and tumor-specific cytotoxicity. ( 28075428 )
2017
6
Prognostic significance of preoperative and postoperative CK19 and CEA mRNA levels in peripheral blood of patients with gastric cardia cancer. ( 28293089 )
2017
7
Radiographic and symptomatic brain ischemia in CEA and CAS: A systematic review and meta-analysis. ( 29021357 )
2017
8
Predictive Role of CYFRA21-1 and CEA for Subsequent Docetaxel in Non-small Cell Lung Cancer Patients. ( 28870944 )
2017
9
Prognostic Significance of Serum CEA for Non-small Cell Lung Cancer Patients Receiving Stereotactic Body Radiotherapy. ( 28870949 )
2017
10
Predictive Value of CEA for Survival in Stage I Rectal Cancer: a Population-Based Propensity Score-Matched Analysis. ( 27067235 )
2016
11
Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people. ( 27002755 )
2016
12
Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei. ( 27038681 )
2016
13
Mutational Profiles Reveal an Aberrant TGF-I^-CEA Regulated Pathway in Colon Adenomas. ( 27100181 )
2016
14
Salivary Levels of ErbB2 and CEA in Oral Squamous Cell Carcinoma Patients. ( 27165212 )
2016
15
Comparison of EMA,CEA, CD10 and Bcl-2 Biomarkers by Immunohistochemistry in Squamous Cell Carcinoma and Basal Cell Carcinoma of the Skin. ( 27039776 )
2016
16
The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. ( 27695943 )
2016
17
Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients. ( 27561099 )
2016
18
Evaluation of predictive value of pleural CEA in patients with pleural effusions and histological findings: A prospective study and literature review. ( 27521620 )
2016
19
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial). ( 27234640 )
2016
20
Monitoring the treatment outcome in endometrial cancer patients by CEA and TATI. ( 26779635 )
2016
21
ZKSCAN3 Facilitates Liver Metastasis of Colorectal Cancer Associated with CEA-expressing Tumor. ( 27127149 )
2016
22
The association between preoperative serum CEA concentrations and synchronous liver metastasis in colorectal cancer patients. ( 26756614 )
2016
23
A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-I+-2b in patients with CEA-expressing carcinomas. ( 27581603 )
2016
24
Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge. ( 27327081 )
2016
25
[Determination of CEA, EGFR and hTERT expression in peritoneal lavage in patients with pancreatic adenocarcinoma using RT - PCR method]. ( 26766154 )
2015
26
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer. ( 26207909 )
2015
27
Concordance of Hypermethylated DNA and the Tumor Markers CA 15-3, CEA, and TPA in Serum during Monitoring of Patients with Advanced Breast Cancer. ( 26339655 )
2015
28
Changing patterns of Serum CEA and CA199 for Evaluating the Response to First-line Chemotherapy in Patients with Advanced Gastric Adenocarcinoma. ( 25921105 )
2015
29
Serum carcinoembryonic antigen (CEA) as a clinical marker in acquired idiopathic generalized anhidrosis: a close correlation between serum CEA level and disease activity. ( 26446433 )
2015
30
Prognostic value of serum CYFRA21-1 and CEA for non-small-cell lung cancer. ( 26333429 )
2015
31
CEA serum level as early predictive marker of outcome during EGFR-TKI therapy in advanced NSCLC patients. ( 25731731 )
2015
32
MC32 tumor cells acquire Ag-specific CTL resistance through the loss of CEA in a colon cancer model. ( 25902414 )
2015
33
Recruiting RCTs comparing CAS, CEA and best medical treatment for asymptomatic carotid stenosis. ( 26327611 )
2015
34
Inhibition of CEA release from epithelial cells by lipid A of Gram-negative bacteria. ( 26208386 )
2015
35
Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals. ( 26254391 )
2015
36
Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement. ( 26162539 )
2015
37
Diagnostic performance of CD66c in lung adenocarcinoma-associated malignant pleural effusion: comparison with CEA, CA 19-9, and CYFRA 21-1. ( 25551300 )
2015
38
The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients. ( 26408719 )
2015
39
TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuximab for metastatic colorectal cancer. ( 25608838 )
2015
40
Clinical significance of joint detection of serum CEA, SCCA, and bFGF in the diagnosis of lung cancer. ( 26464712 )
2015
41
Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases. ( 25582745 )
2015
42
Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer. ( 25987051 )
2015
43
Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors. ( 25895046 )
2015
44
Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer-A retrospective analysis of kinetics on 743 breast cancer patients. ( 26160053 )
2015
45
Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer. ( 24879526 )
2014
46
Analysis of CEA expression and EGFR mutation status in non-small cell lung cancers. ( 24870738 )
2014
47
Nicotine dependence produces hyperalgesia: Role of corticotropin-releasing factor-1 receptors (CRF1Rs) in the central amygdala (CeA). ( 24107576 )
2014
48
Preliminary evaluation of clinical utility of CYFRA 21-1, CA 72-4, NSE, CA19-9 and CEA in stomach cancer. ( 24998567 )
2014
49
Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer. ( 25124614 )
2014
50
CA 19-9 as a marker in addition to CEA to monitor colorectal cancer. ( 25442815 )
2014

Variations for Chronic Enteropathy Associated with Slco2a1 Gene

Expression for Chronic Enteropathy Associated with Slco2a1 Gene

Search GEO for disease gene expression data for Chronic Enteropathy Associated with Slco2a1 Gene.

Pathways for Chronic Enteropathy Associated with Slco2a1 Gene

GO Terms for Chronic Enteropathy Associated with Slco2a1 Gene

Sources for Chronic Enteropathy Associated with Slco2a1 Gene

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....